Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Markiewicz

Oral & Maxillofacial Surgery Buffalo, NY Medical Doctor

NPI 1225291347 CMS profile 236570

3435 Main St, Buffalo, NY 14214

Open in the dashboard

General payments

$60,950

184 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Markiewicz of Buffalo, NY is reported in the CMS Open Payments database as having received $60,950 across 184 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,463 17
2024 General $10,492 33
2023 General $5,715 38
2022 General $13,236 37
2021 General $12,823 21
2020 General $9,409 13
2019 General $5,811 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Markiewicz
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Michael Markiewicz were reported at $3,463. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Michael Markiewicz Oral & Maxillofacial Surgery median Middle half National median
2019 $5,811 $178 $56–$584 $163
2020 $9,409 $106 $38–$316 $114
2021 $12,823 $165 $57–$511 $132
2022 $13,236 $173 $63–$494 $149
2023 $5,715 $184 $62–$521 $160
2024 $10,492 $197 $65–$603 $164
2025 $3,463 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $22,264 50 payments
  2. Synthes GmbH $16,350 27 payments
  3. KLS-Martin L.P. $15,879 61 payments
  4. Medical Device Business Services, Inc. $2,020 1 payment
  5. Stryker Corporation $1,732 16 payments
  6. Inspire Medical Systems, Inc. $1,604 11 payments
  7. DePuy Synthes Sales Inc. $587 12 payments
  8. Kerecis Limited $264 1 payment
  9. Integra LifeSciences Corporation $169 1 payment
  10. Dentsply Sirona Inc $45 3 payments
  11. Other $35 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $13,690 5 payments
  2. Travel and Lodging $12,221 39 payments
  3. Food and Beverage $10,909 126 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $8,700 8 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,300 2 payments
  6. Honoraria $3,750 2 payments
  7. Debt forgiveness $2,879 1 payment
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,500 1 payment
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $21,820 45 payments
  2. AXOGUARD NERVE PROTECTOR $9,599 14 payments
  3. AxoGuard Nerve Connector $9,599 14 payments
  4. TRUMATCH $2,542 11 payments
  5. INSPIRE $1,604 11 payments
  6. NA Craniomaxillofacial $887 5 payments
  7. VSP SYSTEM, VSP CRANIAL $379 5 payments
  8. NA Craniomaxillofacial $368 4 payments
  9. Kerecis Omega3 SurgiClose $264 1 payment
  10. Kerecis Omega3 Marigen $264 1 payment
  11. Other $3,461 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Maxillofacial Surgery: 343

Drug cost

$74

Median for Maxillofacial Surgery: $1,437

Branded share of claims

100%

Median for Maxillofacial Surgery: 21.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 11 $74

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$23,900

Medicare's payments for the services billed

Medicare patients

55

Average age 69

Services billed

149

27 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 42%
Depression 27%
Ischemic heart disease 24%
Diabetes 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

184 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record